CVS Health Plans to Split into Two Independent Companies

US-based healthcare company CVS Health aims to create two independent publicly traded companies by separating its retail pharmacy and health solutions businesses. According to the company's statement, the separation transaction is subject to obtaining necessary approvals. Under the planned structure, the retail pharmacy business and health solutions operations will operate under separate legal entities. Both units are expected to have publicly traded company status. The separation process is expected to be completed in the first half of 2028, subject to obtaining necessary approvals. The company anticipates a timeline based on approval processes for the timing of the transaction. This move is considered part of CVS Health's strategy to conduct its operations in retail pharmacy and health solutions under separate structures. Not investment advice.

📊 CVS — Piyasa Yorumu

▲ up · 45%

CVS stock fell sharply by 11.8% in 24 hours to $80, with its RSI at 23.5, placing it in oversold territory. MACD is negative and the price is clearly below the SMA20/SMA50, indicating a weak short-term trend. Spin-off news is generally perceived positively in the short term on expectations of value unlocking, and a relief rally could emerge under oversold conditions. However, because the spin-off process involves uncertainty and the technical picture is impaired, any upside may be limited and volatile. I assess the direction as upward but with low confidence.

RSI 14

23.5

MACD

-2.64

24h Δ

-11.78%

Canlı Grafikler